Evidence map›Paper›PMID 39164972›Full record

ArticleActa obstetricia et gynecologica Scandinavica2025

External validation of and improvement upon a model for the prediction of placenta accreta spectrum severity using prospectively collected multicenter ultrasound data.

Magdalena Kolak, Stephen Gerry, Hubert Huras, Ammar Al Naimi, Karin A Fox, Thorsten Braun, Vedran Stefanovic, Heleen van Beekhuizen, Olivier Morel, Alexander Paping and 7 more

Abstract readMulticenter StudyValidation Study
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Magdalena KolakDepartment of Obstetrics and Perinatology, Medical College, Jagiellonian University, Krakow, Poland.ORCID 0000-0002-7822-2434
Stephen GerryCentre for Statistics in Medicine, University of Oxford, Oxford, UK.ORCID 0000-0003-4654-7311
Hubert HurasDepartment of Obstetrics and Perinatology, Medical College, Jagiellonian University, Krakow, Poland.ORCID 0000-0001-6661-6893
Ammar Al NaimiDivision of Obstetrics & Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University Hospital Frankfurt Goethe-University, Frankfurt, Germany.ORCID 0000-0001-5345-4688
Karin A FoxDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0002-8405-772X
Thorsten BraunDepartment of Obstetrics, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-1989-9920
Vedran StefanovicDepartment of Obstetrics and Gynecology, Fetomaternal Medical Center, Helsinki University Hospital and University of Helsinki, Berlin, Finland.ORCID 0000-0001-5230-1698
Heleen van BeekhuizenDepartment of Gynecological Oncology, Erasmus MC Cancer Center, Rotterdam, The Netherlands.ORCID 0000-0001-8899-7412
Olivier MorelDepartment of Obstetrics and Gynecology, CHRU- Nancy, Université de Lorraine, Nancy, France.ORCID 0000-0001-6359-1328
Alexander PapingDepartment of Obstetrics, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0003-2360-6016
Charline BertholdtDepartment of Obstetrics and Gynecology, CHRU- Nancy, Université de Lorraine, Nancy, France.ORCID 0000-0001-9297-5363
Pavel CaldaDepartment of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.ORCID 0000-0002-2903-5026
Zdenek LastuvkaDepartment of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.ORCID 0000-0002-4850-4625
Andrzej JaworowskiDepartment of Obstetrics and Perinatology, Medical College, Jagiellonian University, Krakow, Poland.ORCID 0000-0002-6466-9059
Egle SavukyneHospital of Lithuanian University of Health Sciences Kaunas Clinics, Lithuanian University of Health Sciences, Kaunas, Lithuania.ORCID 0000-0002-5384-0738
Sally CollinsNuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, UK.ORCID 0000-0002-0648-7433
IS‐PAS group

Funding

Všeobecná Fakultní Nemocnice v Praze MH CZ - DRO-VFN64165.
6 · The paper itself

Abstract

introductionThis study aimed to validate the Sargent risk stratification algorithm for the prediction of placenta accreta spectrum (PAS) severity using data collected from multiple centers and using the multicenter data to improve the model. MATERIAL AND

methodsWe conducted a multicenter analysis using data collected for the IS-PAS database. The Sargent model's effectiveness in distinguishing between abnormally adherent placenta (FIGO grade 1) and abnormally invasive placenta (FIGO grades 2 and 3) was evaluated. A new model was developed using multicenter data from the IS-PAS database.

resultsThe database included 315 cases of suspected PAS, of which 226 had fully documented standardized ultrasound signs. The final diagnosis was normal placentation in 5, abnormally adherent placenta/FIGO grade 1 in 43, and abnormally invasive placenta/FIGO grades 2 and 3 in 178. The external validation of the Sargent model revealed moderate predictive accuracy in a multicenter setting (C-index 0.68), compared to its higher accuracy in a single-center context (C-index 0.90). The newly developed model achieved a C-index of 0.74.

conclusionsThe study underscores the difficulty in developing universally applicable PAS prediction models. While models like that of Sargent et al. show promise, their reproducibility varies across settings, likely due to the interpretation of the ultrasound signs. The findings support the need for updating the current ultrasound descriptors and for the development of any new predictive models to use data collected by different operators in multiple clinical settings.

Indexed as

Placenta AccretaUltrasonography, PrenatalAdultAlgorithmsFemaleHumansPredictive Value of TestsPregnancyProspective StudiesReproducibility of ResultsRisk AssessmentSeverity of Illness Indexabnormal adherent placentaabnormal invasive placentaplacenta accreta spectrumprediction modelprobability

Identifiers

PMID39164972
PMCPMC12087402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.